Health
Brisbane biotech company trials drug on US COVID-19 patients in bid to find ‘new way to prevent people dying’ of virus – ABC News
A Brisbane biotech company creates an anti-inflammatory drug which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States…
A Brisbane biotech company, led by award-winning immunologist Ian Frazer, has created an anti-inflammatory drug, which is being trialled as a potential treatment for severely-ill COVID-19 patients in the United States.
Key points:
- The drug is being trailed on 300 people in the US, with results expected in about six months
- If successful, drug IC14 could become part of routine care to treat COVID-19 patients with severe infection
- Professor Ian Frazer says the drug could provide a new way to treat people…
Continue Reading
-
General12 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
Business12 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher
-
General14 hours agoToo skewed, too gentlemanly | The Spectator Australia
-
General15 hours agoAlbanese beats drum on economy as trade clouds gather